Doctors are often failing to inform patients about the risk of birth defects to their potential unborn babies from a commonly used drug to treat epilepsy, according to a literature review by a University of Manchester researcher in the United Kingdom.
The study by PhD student Wejdan Shroukh also reveals that both clinical staff and patients can dangerously misjudge the risk of taking a group of drugs called teratogenic medicines, which are associated with birth defects.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
